Integrin alphavbeta6 mediates the potential for colon cancer cells to colonize in and metastasize to the liver
Open accessThe DOI matches its Crossref record.
Abstract
Integrin alphavbeta6 (αvβ6) is correlated with colon cancer progression. To detect the effects of αvβ6 on liver metastasis, the specificity of αvβ6 against the monoclonal antibody (mAb) 2G2 was examined by immunoprecipitation. Integrin αvβ6‐immunoreactivity (IR) in liver metastasis tissues (63 cases) and colon carcinoma (358 cases) were examined. These results showed that αvβ6 was specifically recognized by the mAb 2G2, and that rates of αvβ6 positivity in liver metastatic tissues (71.4%, 45/63) were higher than that for primary colon cancer (34.0%, 122/358) (P < 0.01). Patients who were αvβ6‐positive had higher liver metastasis rates (17%, 21/122) than those who were αvβ6‐negative (only 3%, 7/236) (P < 0.01). To examine the underlying mechanisms associated with αvβ6 regulating colonic metastasis in the liver, experimental liver metastasis (intrasplenic injection of HT29 transfectants) and liver colonization assays (direct injection of WiDr transfectants into the liver) in nude mice were performed; these demonstrated that αvβ6 contributed to the promotion of the metastatic potential and the survival of cancer cells in the liver. Matrix metalloproteinase‐9 (MMP‐9) levels in the cultures of both HT29 and WiDr cells were detected by the Biotrak MMP‐9 activity assay system and gelatin zymography assay, and showed that suppression of αvβ6‐IR inhibited MMP‐9 activity and secretion. Transwell migration assay in vitro also showed that αvβ6 promoted migration on fibronectin for HT29/WiDr mock compared with HT29/WiDr antisense β6 transfects (P < 0.01). We concluded that αvβ6 may mediate the potential for colon cancer cells to colonize in and metastasize to the liver. The mechanisms that αvβ6 may be involved in include the promotion of MMP‐9 secretion, the enhancement of migration on fibronectin, and the survival of cancer cells in the liver. (Cancer Sci 2008; 99: 879–887)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Extracellular matrix and its therapeutic potential for cancer treatment
Huang, J., Zhang, L., Wan, D., Zhou, L., Zheng, S., Lin, S., & Qiao, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00544-0 · Cited by 962
Voulgari, A., & Pintzas, A. (2009) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2009.03.002 · Cited by 671
Exploring the Role of RGD-Recognizing Integrins in Cancer
Nieberler, M., Reuning, U., Reichart, F., Notni, J., Wester, H.-J., Schwaiger, M., Weinmüller, M., Räder, A., Steiger, K., & Kessler, H. (2017) · Cancers · doi:10.3390/cancers9090116 · Cited by 429
The roles of integrin αvβ6 in cancer
Niu, J., & Li, Z. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.06.012 · Cited by 178
Self-citationKamarajan, P., Ateia, I., Shin, J. M., Fenno, J. C., Le, C., Zhan, L., Chang, A., Darveau, R., & Kapila, Y. L. (2020) · PLOS Pathogens · doi:10.1371/journal.ppat.1008881 · Cited by 134
Metadata
- Authors
- Yang, G., Xu, K., Pan, Z., Zhang, Z., Mi, Y., Wang, J., Chen, R., & Niu, J.
- Venue
- Cancer Science
- Publisher
- Wiley
- Published
- 2008-02-24
- Volume
- 99
- Issue
- 5
- Pages
- 879-887
- ISSN
- 1347-9032 (ISSN-L)
- 1349-7006
- OpenAlex
- W1990832247
- Cited by
- 109
- References
- 0
- FWCI
- 3.32
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Integrin alphavbeta6 mediates the potential for colon cancer cells to colonize in and metastasize to the liver. https://app.cochat.ai/papers/10.1111/j.1349-7006.2008.00762.x
- The paper
- Yang, G., Xu, K., Pan, Z., Zhang, Z., Mi, Y., Wang, J., Chen, R., & Niu, J. (2008). Integrin alphavbeta6 mediates the potential for colon cancer cells to colonize in and metastasize to the liver. Cancer Science. https://doi.org/10.1111/j.1349-7006.2008.00762.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.